HighPRDM16expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated toFLT3-ITD,KMT2A-PTD, andNUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial-Reference-Cited by-同舟云学术

HighPRDM16expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated toFLT3-ITD,KMT2A-PTD, andNUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial

Published:2015-12-18 Issue:4 Volume:172 Page:581-591
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Shiba Norio¹²,Ohki Kentaro¹,Kobayashi Tohru³,Hara Yusuke¹²,Yamato Genki¹²,Tanoshima Reo⁴,Ichikawa Hitoshi⁵,Tomizawa Daisuke⁶,Park Myoung-ja¹,Shimada Akira⁷,Sotomatsu Manabu¹,Arakawa Hirokazu²,Horibe Keizo⁸,Adachi Souichi⁹,Taga Takashi¹⁰,Tawa Akio¹¹,Hayashi Yasuhide¹

Affiliation:

1. Department of Haematology/Oncology; Gunma Children's Medical Centre; Shibukawa Japan

2. Department of Paediatrics; Gunma University Graduate School of Medicine; Maebashi Japan

3. Division of Clinical Research Planning; Department of Development Strategy; Centre for Clinical Research and Development; National Centre for Child Health and Development; Tokyo Japan

4. Department of Paediatrics; Yokohama City University Hospital; Yokohama Japan

5. Division of Genetics; National Cancer Centre Research Institute; Tokyo Japan

6. Division of Leukaemia and Lymphoma; Children's Cancer Centre; National Centre for Child Health and Development; Tokyo Japan

7. Department of Paediatrics; Okayama University Hospital; Okayama Japan

8. Clinical Research Centre; National Hospital Organization Nagoya Medical Centre; Nagoya Japan

9. Department of Human Health Sciences; Kyoto University Graduate School of Medicine; Kyoto Japan

10. Department of Paediatrics; Shiga University of Medical Science; Ohtsu Japan

11. Department of Paediatrics; National Hospital Organization Osaka National Hospital; Osaka Japan

Funder

Cancer Research Grant

Grant for Research on Children and Families

Ministry of Health, Labour, and Welfare of Japan

Scientific Research

Ministry of Education, Culture, Sports, Science, and Technology

National Institute of Biomedical Innovation

Japan Agency for Medical Research and Development

Kawano Memorial Public Interest Incorporated Foundation for Promotion of Paediatrics

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13869/fullpdf

Reference32 articles.

1. Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value;Abbas;Blood,2010

2. Low frequency of MLL-partial tandem duplications in pediatric acute myeloid leukemia using MLPA as a novel DNA screenings technique;Balgobind;European Journal of Cancer,2010

3. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program;Beillard;Leukemia,2003

4. Mutation in TET2 in myeloid cancers;Delhommeau;The New England Journal of Medicine,2009

5. Genetics of myeloid malignancies: pathogenetic and clinical implications;Frohling;Journal of Clinical Oncology,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted gene sequencing and transcriptome sequencing reveal characteristics of NUP98 rearrangement in pediatric acute myeloid leukemia;European Journal of Medical Research;2024-09-02

2. Unravelling the function of prdm16 in human tumours: A comparative analysis of haematologic and solid tumours;Biomedicine & Pharmacotherapy;2024-09

3. Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers;PLOS ONE;2024-08-23

4. Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study;International Journal of Hematology;2024-03-09

5. High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core‐binding factor;Pediatric Blood & Cancer;2023-12-06